Evidence map›Paper›PMID 29142135›Full record

ArticleJournal of virology2018

Autographa californica Nucleopolyhedrovirus AC141 (Exon0), a Potential E3 Ubiquitin Ligase, Interacts with Viral Ubiquitin and AC66 To Facilitate Nucleocapsid Egress.

Siddhartha Biswas, Leslie G Willis, Minggang Fang, Yingchao Nie, David A Theilmann

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Siddhartha BiswasPlant Science, Faculty of Land Food Systems, University of British Columbia, Vancouver, BC, Canada.
Leslie G WillisSummerland Research and Development Center, Agriculture and Agri-Food Canada, Summerland, BC, Canada.
Minggang FangSummerland Research and Development Center, Agriculture and Agri-Food Canada, Summerland, BC, Canada.
Yingchao NieSummerland Research and Development Center, Agriculture and Agri-Food Canada, Summerland, BC, Canada.
David A TheilmannPlant Science, Faculty of Land Food Systems, University of British Columbia, Vancouver, BC, Canada david.theilmann@agr.gc.ca.
Agriculture and Agri-Food Canada · CAUniversity of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the infection cycle of Autographa californica multiple nucleopolyhedrovirus (AcMNPV), two forms of virions are produced, budded virus (BV) and occlusion-derived virus (ODV). Nucleocapsids that form BV have to egress from the nucleus, whereas nucleocapsids that form ODV remain inside the nucleus. The molecular mechanism that determines whether nucleocapsids remain inside or egress from the nucleus is unknown. AC141 (a predicted E3 ubiquitin ligase) and viral ubiquitin (vUbi) have both been shown to be required for efficient BV production. In this study, it was hypothesized that vUbi interacts with AC141, and in addition, that this interaction was required for BV production. Deletion of both

Indexed as

Active Transport, Cell NucleusAnimalsMass SpectrometryNucleocapsidNucleocapsid ProteinsNucleopolyhedrovirusesSf9 CellsSpodopteraUbiquitinUbiquitin-Protein LigasesVirus AssemblyVirus ReleaseNucleocapsid ProteinsUbiquitinUbiquitin-Protein LigasesAC141AC66AcMNPVbudded virus (BV)cellular ubiquitinnucleocapsidsocclusion-derived virus (ODV)RING motifubiquitinationviral ubiquitinVP80

Identifiers

PMID29142135
PMCPMC5774878
OpenAlexW2769444643

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.